Swish Club Rebrands as SwishX, Pivots from IT Leasing to AI Tools for Pharma

Bengaluru-based startup Swish Club has rebranded itself as SwishX and pivoted from IT asset management to become an agentic AI platform for pharmaceutical and medtech companies, the company announced in May 2026.

SwishX now offers four AI-driven products: Tender IQ, which crawls government portals to match enterprises with relevant tenders; Contract IQ, which automates contracting processes with private hospitals; Marketing IQ, which helps pharma marketing teams engage with doctors; and Channel IQ, which supports sales scaling through distributors and standalone pharmacies.

The company was founded in 2023 by Dushyant Sapre, Suraj Kumar, and Jai Anand. Over roughly three years, Swish Club raised $4.5 million operating as a device leasing platform that allowed enterprises to rent laptops and smartphones. That model was wound down at the end of last year.

Sapre told Inc42 that the original business was capital-intensive, required constant funding to maintain inventory, and offered little differentiation beyond interest rates. “It’s incredibly hard to scale it beyond India,” he said, citing the company’s goal of serving 10,000 customers globally as a key reason for the change.

The transition involved layoffs of sales staff and a ramp-up of engineering teams to build the new AI product. Sapre said SwishX began generating revenue from the outset and currently reports an annual recurring revenue of $1 million. The startup is targeting $5 million in contracted ARR and more than 100 enterprise clients by the end of FY27.

SwishX also plans to expand into Latin America, Southeast Asia, the Middle East, Africa, and Eastern Europe — markets where, Sapre noted, pharmaceutical distribution structures are similar to India’s. The company said some existing pharma clients have already used the platform for offshore operations in those regions.

Looking further ahead, SwishX aims to cover the full lifecycle of generic medicines, from discovery and development through to commercial execution across multiple markets. The startup also plans to raise a larger funding round.

Source: Inc42 Media

This article was generated by AI and cites original sources.